Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2798 results

Press release / Jun 01, 2026

Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML

Growing improvement in major molecular response (MMR) rates demonstrated with Scemblix vs. all standard-of-care TKIs including imatinib and second generation (2G) TKIs1 Clinically relevant 15.2%…
External Partner Risk Management (EPRM)
Event calendar
Oncology
Clinical Trials / May 29, 2026

A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis
Clinical Trials / May 27, 2026

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Clinical Trials / May 27, 2026

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
Clinical Trials / May 22, 2026

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Clinical Trials / May 15, 2026

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany
Clinical Trials / May 11, 2026

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment